mTOR expression and activity patterns in gastroenteropancreatic neuroendocrine tumours

Atsuko Kasajima(Technical University of Munich), Wilko Weichert(Deutsches Konsortium für Translationale Krebsforschung)

Endocrine Related Cancer

December 15, 2010

10.1677/erc-10-0126

Cited by 103

Related Papers

Fungi and inflammatory bowel diseases: Alterations of composition and diversity

|Scandinavian Journal of Gastroenterology|2008|432

Google Goes Cancer: Improving Outcome Prediction for Cancer Patients by Network-Based Ranking of Marker Genes

|PLoS Computational Biology|2012|216

SUMO pathway inhibition targets an aggressive pancreatic cancer subtype

|Gut|2020|100

Loss of SOX2 expression induces cell motility via vimentin up‐regulation and is an unfavorable risk factor for survival of head and neck squamous cell carcinoma

|Molecular Oncology|2015|69

Procoagulant platelets promote immune evasion in triple-negative breast cancer

|Blood|2024|33